Free, Interactive Workshop Features CML Expert, Jorge Cortes, M.D.
WHITE PLAINS, N.Y., Sept. 6 /PRNewswire/ -- Jorge Cortes, M.D., an expert on leukemia, will discuss novel treatment approaches for chronic myelogenous leukemia (CML) in a free telephone workshop entitled CML: A Model in Cancer Therapy. The program is scheduled for Thursday, Sept. 20, 2007, 12:00 p.m. - 1:00 p.m. ET.
The program is being offered by The Leukemia & Lymphoma Society, the leading source of information and support for patients battling leukemia, lymphoma and myeloma, and is supported by an unrestricted educational grant from Novartis.
Dr. Cortes is the deputy chair for the department of leukemia and professor of medicine and internist at The University of Texas M.D. Anderson Cancer Center in Houston, TX. His presentation will address the latest treatment options, emerging therapies, the role of clinical trials and quality of life considerations. A question-and-answer period will follow.
"Dr. Cortes will discuss the promising advances in CML treatment, and provide guidance on the importance of monitoring CML treatment and progress," says Robin Kornhaber, M.S.W., The Leukemia & Lymphoma Society's senior vice president of patient services.
The program is approved for 1.0 Continuing Education Unit for nurses and social workers upon verification of completion.
Registrants will receive an information packet and toll-free dial-in number within 48 hours of signing up. Participants can register online through http://www.lls.org/cmllinks or by phone at (866) 992-9950 ext. 302.
About Chronic Myelogenous Leukemia
CML is called by several names, including chronic granulocytic, chronic
myelocytic or chronic myeloid leukemia. CML results from a change to the
DNA of a stem cell in the marrow. Scientists do not yet understand what
produces this change in the DNA, which is not
|SOURCE The Leukemia & Lymphoma Society|
Copyright©2007 PR Newswire.
All rights reserved